Limited period discount :Sponsored Articles, Homepage Banners and News Release. Write to us - [email protected]

Biotech startup building research facility in Vancouver, B.C. for radiotherapies lands $75M

1 Mins read

Alpha-9 Theranostics, a Vancouver, B.C. and Boston-based biotech company developing radiotherapies, raised $75 million. The company was founded by researchers from the University of British Columbia and BC Cancer, and is led by David Hirsch, a venture partner at Longitude Capital, which led a previous $11 million Series A funding round.

Read more about this at

544 posts

About author
Andrew Sabastian is a tech whiz who is obsessed with everything technology. Basically, he's a software and tech mastermind who likes to feed readers gritty tech news to keep their techie intellects nourished.